Developments in the Space of New MAPK Pathway Inhibitors for BRAF-Mutant Melanoma
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-18-0836
Abstract: The characterization of the MAPK signaling pathway has led to the development of multiple promising targeted therapy options for a subset of patients with metastatic melanoma. The combination of BRAF and MEK inhibitors represents an… read more here.
Keywords: space new; mapk pathway; melanoma; developments space ... See more keywords